問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Thoracic Medicine

Division of Infectious Disease

Division of General Internal Medicine

更新時間:2023-09-19

林恕民Lin, Shu-Min
  • Principal Investigator
  • Clinical Trial Experience (year) 24 years

篩選

List

44Cases

2024-08-01 - 2025-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2006-11-01 - 2008-05-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2008-10-22 - 2010-10-22

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2014-06-30 - 2017-06-30

Phase III

Mepolizumab vs. Placebo as add-on treatment for frequently exacerbating COPD patients characterized by eosinophil level
  • Condition/Disease

    COPD

  • Test Drug

    Mepolizumab

Participate Sites
5Sites

Terminated4Sites

Study ended1Sites

徐武輝
China Medical University Hospital

Division of General Internal Medicine

1 2 3 4 5